Business Results for Fiscal 2018
Third Medium-Term Management Plan (Fiscal 2019 – Fiscal 2021)

from the beginning

Business Results for Fiscal 2018

• Consolidated Performance for Fiscal 2018

Second Medium-Term Management Plan (FY 2016 - FY 2018) Summary

• Historical 10-Year ROE Trends (FY 2009 - FY 2018)

• Annual Average Growth Rate for Three Drug-fostering Formulations (Daikenchuto, Yokukansan & Rikkunshito)

• Issues with Quantitative Goals

Progress with Long-Term Business Vision

• Long-Term Business Vision for 2021

• The Kampo Company -Diverse Delivery Track Record to a Number of Facilities-

• The Kampo Company -Rise in Doctors Prescribing 10 or More Prescription Kampo Products-

• The Kampo Company -Sales Volume Trends for 129 Prescription Kampo Products-

• The Kampo Company -Kampo Medical Training at Universities and Medical Schools-

• The Kampo Company -Medical Education Model Core Curriculum-

• The “People” Company -Establish the Tsumura Academy-

• The “Global Niche” Company -Development of TU-100 (Daikenchuto)- [1]

• The “Global Niche” Company -Development of TU-100 (Daikenchuto)- [2]

• The “Global Niche” Company -Business in China-

• Cash Flows (FY 2016 - FY 2018)

• Trends for Inventory Assets & Sales of 129 Prescription Kampo Products

• CAPEX

Reference Materials

• Consolidated Performance in Fiscal 2018

• Key Points in Performance

• Factors in Increase / Decrease of Operating Profit

• Financial Condition / Cash Flow Position

• FY 2018 Sales Trends for Top 10 Ranking Prescription Kampo Products

Inquiries related to these materials

Third Medium-Term Management Plan (Fiscal 2019 - Fiscal 2021)

• Philosophy-Based Management

• Long-Term Business Vision for 2021

• Roadmap to Realizing Our Long-Term Vision

• Business Environment: Demographics

• Business Environment: Demand for Kampo Preparations Based on NDB Open Data

• Business Environment: The Number of Patients with Dementia

• Business Environment: Change in Female Employment Rate

• Business Environment: The Number of Cancer Sufferers

• Business Environment: The Chinese Market [1]

• Business Environment: The Chinese Market [2]

• Business Environment: The Chinese Market [3]

• Numerical Targets (FY 2021)

• Business Strategy

• Strategic Challenges

• Sales Measures

• Building Evidence

• TU-100 (Daikenchuto) Development

• The Chinese Business [1]

• The Chinese Business [2]

• Efficiency Measures to Improve Productivity

• Optimizing the Overall Group Supply Chain

• Effective Resource Distribution

• Training Personnel Who Can Implement Philosophy-Based Management

• Efforts Towards SDGs

• Shareholder Return Policy

• FY 2019 Earnings Forecast

Inquiries related to these materials